Skip to main content
. Author manuscript; available in PMC: 2022 Jan 20.
Published in final edited form as: Ann Hematol. 2020 Jun 1;100(1):143–155. doi: 10.1007/s00277-020-04094-3

Table 3.

Multivariable analyses of time to AF in patients with no AF at ibrutinib start (n = 290) and in the subset with no prior history of AF (n = 269)

Parameter At risk for AF (n = 290) No prior history of AF (n = 269)
HR (95% CI) p value HR (95% CI) p value
Age > = 65 1.79 (0.84–3.83) 0.13 2.20 (0.90–5.39) 0.08
Hypertension 1.04 (0.53–2.03) 0.92 1.15 (0.49–2.70) 0.74
Heart failure 3.42 (1.53–7.66) 0.003 2.51 (0.98–6.42) 0.06
Valvular heart disease 1.36 (0.54–3.40) 0.51 2.48 (0.95–6.46) 0.06
History of AF 3.48 (1.42–8.66) 0.007

Italicized table entries indicate P-value < 0.05